Detalhe da pesquisa
1.
T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.
Breast Cancer Res Treat
; 176(3): 569-577, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31069590
2.
Homologous Recombination Repair Gene Alterations Are Associated with Tumor Mutational Burden and Survival of Immunotherapy.
Cancers (Basel)
; 15(23)2023 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067312
3.
Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast Cancer.
Cancers (Basel)
; 15(18)2023 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760424
4.
CCND1 Copy Number Variation in Circulating Tumor DNA from Luminal B Breast Cancer Patients.
Anticancer Res
; 42(8): 4071-4077, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35896251
5.
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.
Cancer Med
; 10(5): 1605-1613, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452761
6.
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer.
Anticancer Res
; 41(8): 4143-4149, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34281885
7.
Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Cancer Med
; 10(2): 529-539, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274848
8.
Microsatellite instability in Japanese female patients with triple-negative breast cancer.
Breast Cancer
; 27(3): 490-498, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907878
9.
QOL-enhancing surgery for patients with HER2-positive metastatic breast cancer.
BMJ Support Palliat Care
; 9(2): 151-154, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30254019
10.
Prediction of Negative Outcomes in Non-Surgical Treatment for Appendiceal Abscess in Adults.
J Anus Rectum Colon
; 2(2): 59-65, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-31583322